RecruitingPhase 3NCT03955445
Rare condition
Dense deposit disease
4
studies recruiting now
as of 7 Sept 2026
19
studies registered in total
as of 7 Sept 2026
19
countries with a recruiting site
as of 7 Sept 2026
18 Feb 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT07416162
A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 Glomerulopathy
RecruitingPhase 2NCT04183101
Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy
RecruitingNCT06065852
National Registry of Rare Kidney Diseases
Showing the 4 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Dense deposit disease studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Dense deposit disease study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Dense deposit disease
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (CFH, CFHR1).
Treatments being studied
1 approved treatment and 2 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Pegcetacoplan (Aspaveli)
Phase 1Eculizumab (Bekemv)
Phase 1Sulodexide
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).